Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges

Elvira Immacolata Parrotta,Valeria Lucchino,Luana Scaramuzzino,Stefania Scalise,Giovanni Cuda

DOI: https://doi.org/10.3390/ijms21124354

IF: 5.6

2020-06-19

International Journal of Molecular Sciences

Abstract:Cardiovascular diseases (CVDs) are a class of disorders affecting the heart or blood vessels. Despite progress in clinical research and therapy, CVDs still represent the leading cause of mortality and morbidity worldwide. The hallmarks of cardiac diseases include heart dysfunction and cardiomyocyte death, inflammation, fibrosis, scar tissue, hyperplasia, hypertrophy, and abnormal ventricular remodeling. The loss of cardiomyocytes is an irreversible process that leads to fibrosis and scar formation, which, in turn, induce heart failure with progressive and dramatic consequences. Both genetic and environmental factors pathologically contribute to the development of CVDs, but the precise causes that trigger cardiac diseases and their progression are still largely unknown. The lack of reliable human model systems for such diseases has hampered the unraveling of the underlying molecular mechanisms and cellular processes involved in heart diseases at their initial stage and during their progression. Over the past decade, significant scientific advances in the field of stem cell biology have literally revolutionized the study of human disease in vitro. Remarkably, the possibility to generate disease-relevant cell types from induced pluripotent stem cells (iPSCs) has developed into an unprecedented and powerful opportunity to achieve the long-standing ambition to investigate human diseases at a cellular level, uncovering their molecular mechanisms, and finally to translate bench discoveries into potential new therapeutic strategies. This review provides an update on previous and current research in the field of iPSC-driven cardiovascular disease modeling, with the aim of underlining the potential of stem-cell biology-based approaches in the elucidation of the pathophysiology of these life-threatening diseases.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the challenges faced in the research and treatment of cardiovascular diseases (CVDs), especially how to better understand and simulate the molecular mechanisms and cellular processes of heart diseases. Specifically, the paper explores the methods of using cardiomyocytes derived from induced pluripotent stem cells (iPSCs) to model the mechanisms of heart diseases. These methods aim to overcome the limitations of traditional animal models and human primary cells in research, providing a more reliable and accurate platform to study the early events and development processes of heart diseases, thereby providing potential targets and strategies for the development of new treatment methods.

The main objectives of the paper can be summarized as follows:
1. **Provide updates**: Review and update the latest progress in cardiovascular disease modeling using iPSCs.
2. **Emphasize potential**: Emphasize the potential of stem - cell - based biology methods in revealing the pathophysiology of these life - threatening diseases.
3. **Address challenges**: Discuss the challenges encountered in heart disease research using iPSCs technology and propose possible solutions.

Through these objectives, the paper hopes to promote basic research and clinical applications of heart diseases, especially in the in - depth understanding of disease mechanisms and the exploration of new drug development and personalized treatment strategies.